NeuroOne Medical Technologies Corporation
NMTC
$0.75
$0.011.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 70.73% | 55.90% | 48.43% | 46.64% | -3.87% |
| Total Depreciation and Amortization | 6.00% | 6.61% | 7.86% | 14.00% | 23.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -53.55% | -32.36% | -6.39% | 44.83% | 67.58% |
| Change in Net Operating Assets | 55.04% | 92.86% | 98.46% | -71.65% | 60.69% |
| Cash from Operations | 74.23% | 64.63% | 58.78% | 47.03% | 14.55% |
| Capital Expenditure | 32.03% | 23.35% | 70.12% | 73.76% | 68.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 32.03% | 19.04% | -110.69% | -104.14% | -104.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 63.76% | -5.61% | -73.36% | -53.14% | -31.66% |
| Repurchase of Common Stock | -53.19% | -64.21% | -282.71% | 40.57% | 31.88% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -198.64% | 117.43% | 203.07% | 193.26% | 238.14% |
| Cash from Financing | 10.45% | 5.93% | -61.28% | -35.55% | -1.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 232.31% | 538.65% | 4.55% | 22.14% | -36.10% |